S H Subramony

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Biogen/Reata
    Topic:
    Clinical trial
    Date added:
    10/12/2026
    Date updated:
    10/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Avidity/Novartis
    Topic:
    Clinical trial
    Date added:
    10/12/2026
    Date updated:
    10/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Vertex
    Topic:
    Clinical trial
    Date added:
    10/12/2026
    Date updated:
    10/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Arthex
    Topic:
    Clinical trial
    Date added:
    10/12/2026
    Date updated:
    10/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Dyne
    Topic:
    Clinical trial
    Date added:
    10/12/2026
    Date updated:
    10/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    PTC
    Topic:
    Clinical trial
    Date added:
    10/12/2026
    Date updated:
    10/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Sanofi
    Topic:
    Clinical trial
    Date added:
    10/12/2026
    Date updated:
    10/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Larimar
    Topic:
    Clinical trial
    Date added:
    10/12/2026
    Date updated:
    10/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Avidity
    Date added:
    10/12/2026
    Date updated:
    10/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Fulcrum
    Date added:
    10/12/2026
    Date updated:
    10/12/2026

Pages

Return to TREAT-NMD LGMD Masterclass